Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
22 February 2024 | Story Leonie Bolleurs | Photo SUPPLIED
Action Learning Workshop 2024
Along with Prof Richard Teare (far right) are some of the workshop attendees, which consisted of a group of 15 students, academics, and community organisation leaders.

The Directorate Community Engagement at the University of the Free State (UFS) recently hosted Prof Richard Teare, the President of the Global University of Lifelong Learning (GULL). During his visit, he presented a workshop on action learning.

GULL, established 17 years ago, offers lifelong learning opportunities for people in communities and workplace organisations around the world. It provides frameworks and awards in support of lifelong learning.

Prof Teare described what the process of action learning entails and how it differs from the notion of ‘training’. According to him, action learning occurs when people learn from each other, create their own resources, identify their own problems, and form their own solutions. He stated, “The process is so enriching that every learner is able to identify personal and life-transforming outcomes. These commonly include expressions of enhanced self-confidence, self-belief, renewal, enthusiasm for learning, a new sense of direction and purpose for career and life – along with news skills, insights, and the sense of being equipped for the future.”

The workshop, attended by a group of 15 students, academics, and community organisation leaders, had an element of self-directed development, according to Dr Karen Venter, Head of the Division of Service Learning at the University of the Free State (UFS). “Participants learned how action learning can enable self-directed personal and professional development,” she said.

Skills and leadership characteristics

GULL pathways were also profiled to outline some of the innovative ways in which it can be used to facilitate continuous development aligned with professional certification. It offers three generic pathways, each with five levels (or certification points) leading to professional bachelor’s, master’s, and doctoral degrees,” explained Dr Venter.

“In practice, community leaders who have obtained one of these professional degrees can now become change agents for community development in their own community organisations, using the action learning pathway and certification offered by GULL,” she said.

Dr Venter added that a group of students from the UFS – the Active Community Citizens through Engaged Scholarship for Sustainability (ACCESS) group – embarked on a Professional Bachelor pathway certified by GULL last year. Not only did the group of 11 students successfully earn certification, including one Level Two certificate, five Level Three diplomas, three advanced diplomas, and one bachelor’s degree at the Engaged Scholarship Awards 2023, but they also developed a range of skills and leadership characteristics during the process. These include eco-brick making, vermiculture and gardening, eco-entrepreneurship, soap and candle making, and creative recycling, to name a few. 

Furthermore, the pathway is underpinned by community-based research to drive initiatives of student structures towards implementing impactful community engagement in three clusters, namely sustainable environment, well-being, and social justice.

Addressing SDGs and embracing Vision 130

Lifelong action learning is one of the innovative approaches for the development of graduate attributes. In this light, the outcomes of not only the action learning workshop, but also the learning opportunities presented by GULL, align with the UFS Vision130. “Using action learning for bringing social change, students can address the United Nations Sustainable Development Goals (SDGs) and embrace the values of the UFS’ Vision130 – impact, care, excellence, sustainability, accountability, and social justice,” stated Dr Venter.

One of the attendees communicated the experience as follows: “I learned that action learning is a process for self-determined personal and professional development – the change starts with me developing myself and then sharing it with others.” 

For further opportunities presented by GULL, visit the website here.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept